Page 4 - Astrazeneca

Nepal receives first batch of AstraZeneca vaccine against Covid from Japan

Nepal received the first batch of AstraZeneca COVID-19 vaccine from Japan on Saturday, local media reports said.

Combining AstraZeneca and mRNA Covid vaccines is effective: Danish study

A growing number of countries are looking at switching to different Covid vaccines for second doses, a measure necessary in Denmark after health authorities discontinued AstraZeneca's vaccine in April

AstraZeneca's nasal vax prevents Covid spread in animal models

The trial, led by researchers including from the US National Institutes of Health (NIH) and the University of Oxford, UK, was published in the journal Science Translational Medicine.

Over 18 and considering the AstraZeneca vaccine? This may help you decide

Let's look at the evidence

Astra's Covid-19 vaccine sales triple in Q2, top $1 billion in H1

Firm exploring whether vaccine biz is sustainable for next 5-10 years: Official

Covishield single jab efficacy drops after 16 weeks in 60+ age grp: Report

The efficacy of the single dose of Oxford-Astrazeneca Covid-19 vaccine Covishield dropped at 16 weeks for those above the age of 60

AstraZeneca to apply for Covid-19 vaccine approval in US later in 2021

AstraZeneca reported first-half revenue of $15.5 billion, up 23 per cent

AstraZeneca finds small clot risk after first dose of Vaxzevria vaccine

No extra risk after second dose shows study led and funded by drug maker

Pfizer, Astra vaccine antibody levels may decline after 2-3 months: Lancet

Total antibody levels start to wane six weeks after complete immunisation with Pfizer and AstraZeneca vaccines, and can reduce by more than 50 per cent over 10 weeks, according to The Lancet journal

Russia OKs testing combination of Sputnik, AstraZeneca vaccine shots

Russia's health officials have given a go-ahead to testing a combination of the AstraZeneca coronavirus shot and the single-dose version of the domestically developed Sputnik V vaccine

What makes Covid-19 delta variant such a threat? Ten questions answered

The delta variant has some characteristics that give it a better chance of causing an infection, which means it escapes initial shield provided by antibodies, but vaccinated people are at a lower risk

Prices of oral diabetes drugs set to fall as patents near expiry date

The diabetes segment has been growing faster than the country's overall drug market

World Coronavirus Dispatch: Australia had no Plan B, it came back to haunt

WHO warns of 'chaos' if individuals mix shots, Astra-Oxford said to be looking at tweaking vaccine to prevent rare clots, and other pandemic-related news across the globe

Sputnik, Astrazeneca mix & match booster dose results expected by July end

RDIF, Russia's sovereign wealth fund, and SII have also announced cooperation to produce the Russian Sputnik vaccine against coronavirus in India.

Canada to donate 17.7 mn AstraZeneca Covid-19 vaccine to other countries

Canada announced its decision to donate 17.7 million doses of the AstraZeneca coronavirus vaccine to low- and middle-income countries

Delta variant prompts countries using AstraZ vaccine to consider boosters

Countries are hoping a booster could bolster protection ahead of the return of colder weather that's optimal for the coronavirus's spread.

Serum Institute may double production of AstraZeneca-Oxford vaccine in 2022

Expect 200-million AstraZeneca vaccine doses next year

6 fully vaccinated people die of Covid in world's most vaccinated country

Of those dead in Seychelles, five had taken Covishield and one had been given Sinopharm.

AstraZeneca partners with Docon to digitise 1,000 clinics across India

Biopharmaceutical company AstraZeneca India (AstraZeneca Pharma India Limited) on Wednesday announced that it has signed a memorandum of understanding with Bengaluru-based health startup, Docon Technologies, for digitising 1,000 clinics across India. Under the partnership, Docon will equip the identified clinics with customised Electronic Medical Record (EMR) systems enabling clinicians to access complete patient history, a joint statement said. "This willgo a long way in helping the clinical community better treat chronic patients and manage long-term complications of non-communicable diseases (NCDs) like diabetes and cardiovascular diseases', it said. Towards reaching the 1,000 clinics goal in 2021, on ground identification and support has been placed in 30 cities. Till now, as a part of the pilot phase, around 200 clinics have been upgraded with many of them being in Tier 1 & 2 towns, the statement said. In addition to providing the clinicians with a three day ..

Serum Institute applies for EU nod through drugmaker AstraZeneca

SII Chief Executive Officer Adar Poonawalla said on Mon­day he had taken it up at the "highest levels".